UnitedHealth Group Incorporated $UNH Shares Sold by Wellington Shields Capital Management LLC

Wellington Shields Capital Management LLC cut its holdings in UnitedHealth Group Incorporated (NYSE:UNH) by 53.1% in the second quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 7,434 shares of the healthcare conglomerate’s stock after selling 8,422 shares during the quarter. Wellington Shields Capital Management LLC’s holdings in UnitedHealth Group were worth $2,319,000 as of its most recent SEC filing.

Several other institutional investors have also modified their holdings of UNH. Seelaus Asset Management LLC raised its position in shares of UnitedHealth Group by 11.7% during the 2nd quarter. Seelaus Asset Management LLC now owns 1,047 shares of the healthcare conglomerate’s stock worth $327,000 after purchasing an additional 110 shares during the last quarter. BCGM Wealth Management LLC lifted its position in shares of UnitedHealth Group by 59.0% in the second quarter. BCGM Wealth Management LLC now owns 6,355 shares of the healthcare conglomerate’s stock valued at $1,983,000 after acquiring an additional 2,359 shares in the last quarter. Tsfg LLC raised its stake in UnitedHealth Group by 10.0% in the 2nd quarter. Tsfg LLC now owns 572 shares of the healthcare conglomerate’s stock valued at $179,000 after purchasing an additional 52 shares during the last quarter. Westside Investment Management Inc. boosted its stake in UnitedHealth Group by 17.2% during the 2nd quarter. Westside Investment Management Inc. now owns 4,016 shares of the healthcare conglomerate’s stock worth $1,254,000 after purchasing an additional 589 shares during the last quarter. Finally, Torray Investment Partners LLC raised its position in shares of UnitedHealth Group by 126.3% in the second quarter. Torray Investment Partners LLC now owns 49,337 shares of the healthcare conglomerate’s stock valued at $15,392,000 after buying an additional 27,539 shares during the last quarter. Institutional investors and hedge funds own 87.86% of the company’s stock.

UnitedHealth Group Stock Performance

Shares of UnitedHealth Group stock opened at $341.46 on Monday. The stock has a market capitalization of $309.31 billion, a price-to-earnings ratio of 17.82, a price-to-earnings-growth ratio of 2.28 and a beta of 0.47. UnitedHealth Group Incorporated has a 12 month low of $234.60 and a 12 month high of $630.73. The company has a debt-to-equity ratio of 0.71, a current ratio of 0.82 and a quick ratio of 0.85. The business has a 50-day moving average of $343.51 and a 200 day moving average of $325.81.

UnitedHealth Group (NYSE:UNH) last announced its quarterly earnings data on Tuesday, October 28th. The healthcare conglomerate reported $2.92 earnings per share for the quarter, beating analysts’ consensus estimates of $2.87 by $0.05. The firm had revenue of $113.16 billion during the quarter, compared to analysts’ expectations of $113.19 billion. UnitedHealth Group had a net margin of 4.04% and a return on equity of 19.23%. The business’s quarterly revenue was up 12.2% compared to the same quarter last year. During the same quarter in the previous year, the business posted $7.15 earnings per share. As a group, sell-side analysts forecast that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current year.

UnitedHealth Group Announces Dividend

The business also recently announced a quarterly dividend, which was paid on Tuesday, September 23rd. Investors of record on Monday, September 15th were issued a $2.21 dividend. The ex-dividend date was Monday, September 15th. This represents a $8.84 dividend on an annualized basis and a yield of 2.6%. UnitedHealth Group’s dividend payout ratio (DPR) is 46.14%.

Analyst Ratings Changes

Several analysts recently issued reports on the stock. UBS Group upped their price objective on shares of UnitedHealth Group from $378.00 to $430.00 and gave the company a “buy” rating in a research note on Wednesday, October 29th. Cantor Fitzgerald restated an “overweight” rating and issued a $440.00 price target on shares of UnitedHealth Group in a research report on Tuesday, August 26th. Jefferies Financial Group boosted their price objective on UnitedHealth Group from $317.00 to $409.00 and gave the stock a “buy” rating in a research note on Friday, October 17th. The Goldman Sachs Group initiated coverage on shares of UnitedHealth Group in a research report on Tuesday, October 14th. They set a “buy” rating and a $406.00 price target on the stock. Finally, Sanford C. Bernstein lifted their target price on shares of UnitedHealth Group from $433.00 to $440.00 and gave the stock an “outperform” rating in a research note on Thursday. Eighteen investment analysts have rated the stock with a Buy rating, nine have assigned a Hold rating and three have given a Sell rating to the stock. According to data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and an average price target of $397.12.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.